(1)
Network Pharmacology and Molecular Docking Identify Eugenol As a Lead Compound Targeting Visceral Leishmaniasis Pathways With Nanotechnology-Driven Drug Design and Nanoscale Interaction Analysis. ETN 2026, 10 (3), 1449-1468. https://doi.org/10.56053/10.3.1449.